0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Cell Grade Beads > DLL4 > MBS-C013

ActiveMax® Human DLL4 μBeads, premium grade (for cells) DMF

Order Now

ProductSizeAmount
ActiveMax® Human DLL4 μBeads, premium grade (for cells)2.5 mg2.5 × 10⁷ beads
ActiveMax® Human DLL4 μBeads, premium grade (for cells)10 mg (2.5 mg × 4)1 × 10⁸ beads
  • Background
    ActiveMax® Human DLL4 μBeads, premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5) , and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.
  • Source
    ActiveMax® Human DLL4 μBeads, premium grade (for cells) are uniform, superparamagnetic beads of 5.5 µm with streptavidin on its surface and coupled with biotinylated Human DLL4 Protein, expressed from human 293 cells (HEK293) and contains AA Ser 27 - Pro 524 (Accession # NP_061947.1 ).
  • Application
    ActiveMax® Human DLL4 μBeads, premium grade (for cells) can activate Notch signaling in hematopoietic stem/progenitor cells (HSPCs), mimicking DLL4+ epithelial cells in the thymus, and then drives T-lineage commitment and differentiation. It can be used for in vitro production of induced pluripotent stem cell derived T cells, such as inducing the differentiation from CD34+ cells to progenitor T cells to TCRαβ T cells in vitro, which provides a simple and robust tool to both study human T cell development and facilitate the development of engineered T cell therapies from renewable sources.
    *We also carry ActiveMax® Streptavidin μBeads, premium grade (for cells)(Cat. No. MBS-C009),and it can be used for convenient preparation of your own sterile protein/antibody coupled beads for cell based assay, cell sorting and other applications. The ActiveMax® Streptavidin μBeads, premium grade can also be used together with other ActiveMax® μBeads, premium grade as Isotype control.
  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage
    This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.Please avoid repeated freeze-thaw cycles after reconstitution. Immediate use after reconstitution is highly recommended.
  • Sterility
    Negative
  • Endotoxin
    Less than 0.002 EU per μg by the LAL method.
  • Important Note
    This product is for research use only and not intended for therapeutic or in vivo diagnostic use.
  • Formulation

    Please contact us for detailed information.

    Contact us for customized product form or formulation.

Typical Data Please refer to DS document for the assay protocol.
 DLL4 TYPICAL DATA

Assay of human DLL4 protein on the μBeads surface by Flow cytomtry.The human DLL4 conjugated on the μBeads (Cat. No. MBS-C013) surface were fluorescently stained using Human Anti-DLL4 Antibody, Mouse IgG1 and PE labeled anti-Mouse IgG1 Antibody, analyzed by flow cytometry (QC tested).

Application Data
 DLL4 APPLICATION DATA

Combinations of ActiveMax® Human DLL4 μBeads (Cat. No. MBS-C013) and ActiveMax® Human VCAM-1 / CD106 μBeads (Cat. No. MBS-C019) could efficiently induce hematopoietic stem cells differentiation into CD56+ NK cells after 20 days of culture, with expression of CD56, NKp46, NKG2D, NKp30 and NKp44.

 DLL4 APPLICATION DATA

The Cell Number of hcCD34P cells-derived CD7+ and CD5+ T-lymphoid progenitors After 21 Days of Culture. Combinations of ActiveMax® Human DLL4 μBeads, premium grade(for cells)(Cat.No.MBS-C013) and Cytokine could efficiently induce hcCD34P cells differentiation into CD7+ and CD5+ T-lymphoid progenitors after 21 days of culture.

  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €1810.00

Price(EUR) : €4430.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:3 Details
  • Latest Research Phase:Phase 3 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message